Immunization With the MAGE-3.A1 Peptide Mixed With the Adjuvant CpG 7909 in Patients With Metastatic Melanoma

Clinical trial NCT00145145 · TERMINATED

Trial details

NCT number: NCT00145145
Sponsor: Ludwig Institute for Cancer Research
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Malignant Melanoma

Start date: 2005-01-12
Primary completion: 2005-04-07
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.